Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on April 3, 2025

Alice Khalkad House of Skin Launches State-of-the-Art Spa, Ushering in a New Era of Skincare Excellence
A dazzling evening of glamour and innovation in skincare. ROSLYN, NY, UNITED STATES, April 3, 2025 /EINPresswire.com/ -- Alice Khalkad, medical aesthetician and founder, proudly unveiled the highly anticipated Alice Khalkad House of Skin spa, marking a …

PANDAS Physicians Network Awards Funding to the Agalliu Lab for Immune Mediated OCD, PANDAS/PANS Research
This research will provide important insights into how the immune system and inflammation affect brain function, particularly in children with PANDAS/PANS. MOORESVILLE, NC, UNITED STATES, April 3, 2025 /EINPresswire.com/ -- The PANDAS Physicians Network …

Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. Tariffs
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the status of its products in relation to the U.S. Government’s …

Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS, Showing Rapid and Durable Benefit Across Clinical Measures and Time Points Educational Symposium Focuses on Advancing GBS Care and …

Praxis Precision Medicines to Participate in Upcoming April Conferences
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …

Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
MONTREAL, April 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results and provide a …

Theratechnologies annoncera ses résultats financiers du premier trimestre de l’exercice financier de 2025 et fera une mise à jour de ses activités
MONTRÉAL, 03 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui que la Société dévoilera ses résultats financiers …

Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
-- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers -- -- Strengthened Balance Sheet through Sale of Excess Capital Equipment, Raising Approximately $17.0 Million -- …

Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million upfront payment and expand dataset to combination therapy New interim data for the vebreltinib development …

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
VALENCIA, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the U.S. commercial launch of Cohealyx™, a collagen-based …

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on April 1, 2025, it awarded …

I-Mab Reports Full Year 2024 Financial Results and Provides Business Update
Continued positive momentum in givastomig Phase 1b combination trial in first-line gastric cancer, with topline dose escalation data (n=17) expected in 2H 2025 Enrollment completed ahead of schedule in the first givastomig Phase 1b dose expansion cohort; …

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …

Best SARMs For Cutting, Bulking & Muscle Growth 2025: Top Fat Loss Sarms Stack For Sale On The Market - CrazyBulk
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Welcome to the world of SARMs, the selective androgen receptor modulators that have gained popularity in the fitness and bodybuilding community. SARMs offer a unique approach to enhancing muscle growth, …

Arialief Vitamins Reviews & Complaints (EXPOSED 2025) Arialief For Neuropathy and Nerve Health
FINDLAY, Ohio, April 03, 2025 (GLOBE NEWSWIRE) -- Arialief Vitamins is a pure product mainly designed to aid sciatic nerve health. The supplement is prepared with powerful natural ingredients that target the nerve health and neuropathy system. Its main …

Capilea Mexico Celebrates 25 Years as Best Hair Transplant Clinic in Mexico
TIJUANA, Mexico, April 03, 2025 (GLOBE NEWSWIRE) -- Capilea Mexico Hair Transplant Clinic is marking its 25th anniversary as a premier destination for international patients seeking high-quality, affordable hair restoration solutions. The clinic has …

AMPS ClaimInsight Sponsors Health Plan Alliance Spring Leadership Forum, Connecting Industry Leaders to Drive Innovation
PHOENIX, April 03, 2025 (GLOBE NEWSWIRE) -- AMPS, a leader in healthcare cost containment, proudly participated in the Health Plan Alliance Spring Leadership Forum as a sponsor, joining health plan executives from across the country to discuss the most …

Orion Corporation: Organising meeting of the Board of Directors
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 3 APRIL 2025 at 16.25 EEST Orion Corporation: Organising meeting of the Board of Directors In its organising meeting, the Board …

Orion Oyj:n hallituksen järjestäytymiskokous
ORION OYJ PÖRSSITIEDOTE – MUUT PÖRSSIN SÄÄNTÖJEN NOJALLA JULKISTETTAVAT TIEDOT 3.4.2025 KLO 16.25 Orion Oyj:n hallituksen järjestäytymiskokous Orion Oyj:n tänään pidetyssä varsinaisessa yhtiökokouksessa valittu hallitus on …

Vantive Chief Strategy Officer Joins Labviva Board
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Labviva, the leading AI procurement platform for life sciences, today announced the appointment of Ben Daverman to its Board of Directors. Daverman brings decades of expertise in corporate strategy, healthcare …